SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,136 | -13.5% | 11,200 | 0.0% | 0.05% | -20.0% |
| Q2 2023 | $295,120 | +1.3% | 11,200 | 0.0% | 0.06% | -40.9% |
| Q4 2022 | $291,312 | -3.9% | 11,200 | 0.0% | 0.11% | +48.6% |
| Q3 2022 | $303,000 | +2.0% | 11,200 | 0.0% | 0.07% | +13.8% |
| Q2 2022 | $297,000 | -53.0% | 11,200 | 0.0% | 0.06% | -47.2% |
| Q1 2022 | $632,000 | -13.3% | 11,200 | 0.0% | 0.12% | -2.4% |
| Q4 2021 | $729,000 | +15.2% | 11,200 | 0.0% | 0.13% | +9.6% |
| Q3 2021 | $633,000 | -32.6% | 11,200 | 0.0% | 0.12% | -36.8% |
| Q2 2021 | $939,000 | +19.3% | 11,200 | 0.0% | 0.18% | +9.6% |
| Q1 2021 | $787,000 | +4.7% | 11,200 | 0.0% | 0.17% | -2.9% |
| Q4 2020 | $752,000 | +14.8% | 11,200 | 0.0% | 0.17% | -3.9% |
| Q3 2020 | $655,000 | – | 11,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |